Trials / Completed
CompletedNCT03971903
Attention Bias Modification Treatment for Young Adults With Major Depressive Disorder
Department of Psychology, Hunan Normal University
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Hunan Normal University · Academic / Other
- Sex
- All
- Age
- 16 Years – 20 Years
- Healthy volunteers
- Not accepted
Summary
In this study, the investigators test whether a 4-week 12-session attention bias modification treatment (ABMT) could reduce depressive symptoms relative to placebo controls in young adults with major depressive disorder at post-training and 3-month follow-ups. Meanwhile, the investigators also test whether a 2-week 4-session ABMT booster training for every three months could reduce residual depressive symptoms and recurrences relative to placebo controls for 1-year follow-up
Detailed description
Attention Bias Modification Training was a modified dot-probe task, in which 90% of the targets appeared at the neutral word position and 10% at the sad word position. The placebo training procedure is a classic dot-probe task in which the targets appeared with equal probability in the sad (50%) and neutral (50%) word positions. The investigators assess attention bias scores, depressive symptoms, trait anxiety, rumination and self-report attention control ability at 1-week, 2-week, 4-week,7-week,3-month,4-month, 5-month, 6-month and 12-month follow-ups after training.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Attention bias modification | The ABM training task was a variation of the computerized visual dot-probe task. During the training, each session includes 54 neutral-sad word pairs presenting 6 times (6 × 54=324 trials) during 20-minute. Participants received 12 sessions over 4 weeks (1 session every other day). In the active ABMT, 90% of the probes appeared at the neutral position and 10% at the sad position. At the placebo ABMT, 50% of the probes appeared at the neutral position and 50% at the sad position. |
Timeline
- Start date
- 2017-12-24
- Primary completion
- 2019-03-26
- Completion
- 2019-03-26
- First posted
- 2019-06-03
- Last updated
- 2019-06-03
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03971903. Inclusion in this directory is not an endorsement.